Cancer research is a crucial pillar for countries to deliver more affordable, higher quality,
and more equitable cancer care. Patients treated in research-active hospitals have better …

Childhood cancer is a major global health issue. Every year, almost 100 000 children die
from cancer before the age of 15 years, more than 90% of them in resource-limited …

The burden of cancer is growing, and the disease is becoming a major economic
expenditure for all developed countries. In 2008, the worldwide cost of cancer due to …

Western European health systems are not keeping pace with changes in child health needs.
Non-communicable diseases are increasingly common causes of childhood illness and …

Cancer in young people is rare, but it is still a major health issue in Europe. Each year, more
than 6,000 young people in Europe die of cancer. There are more than 300,000 European …

Despite the increase of cure rates in the treatment of children with cancer there is a
significant discrepancy in the outcome within Europe. Data are showing us that there is a …

Approval of new cancer drugs for paediatric patients generally occurs after their
development and approval for treating adult cancers. As most drug development occurs in …

INTRODUCTION: Complementary and alternative medicine (CAM) is used by both adults
and children in Europe. Diverse cultural, ethnic and historical preconditions in European …

Background Complementary and alternative medicine (CAM) is applied both to children and
adults widely throughout the world. A previous pan-European survey showed a surprisingly …

Background In recent years, the European Commission has supported an increased focus
on rare cancers in order to improve quality of care, disseminate best practice and set up …